Roughly 30,000 people in the United States have cystic fibrosis. Worldwide the total is just 70,000.
Such a small number of potential customers means big pharmaceutical companies can’t afford the risk of spending large amounts of money to conduct...
This content is available exclusively to Chronicle subscribers
Already a subscriber?
Log in now
The Chronicle is your leading source of news, information, and jobs specifically designed for nonprofit professionals.
Your subscription includes:
- Unlimited access to the online Resource Center
- Our monthly magazine
- Free access to GrantStation’s exclusive database
- Nonprofit Adviser — a subscriber-only newsletter